Reid Hoffman’s Manas AI raises $24.6M, a fraction of other AI drug discovery startups
LinkedIn founder Reid Hoffman and Siddhartha Mukherjee, cancer researcher and author of the book “The Emperor of All Maladies ...
LinkedIn co-founder Reid Hoffman: DeepSeek AI proves this is now a 'game-on competition' with China
Reid Hoffman, Greylock partner, Inflection AI and LinkedIn co-founder, and ‘Superagency' author, joins 'Squawk Box' to ...
Reid Hoffman says that AI can give you superpowers
The LinkedIn founder talks about his new book, ‘Superagency,’ and argues that people can use AI to reshape their daily work lives.
Reid Hoffman says AI could ultimately benefit the human experience instead of making social isolation worse because it’s ‘infinitely patient’
"You can imagine it being a useful tutor across a wide variety of subjects, including even spiritual or counseling or mental ...
Observer2d
Reid Hoffman Bets on A.I. Drug Discovery with a Pulitzer-Winning Cancer Physician
Hoffman isn’t the only prominent Silicon Valley figure betting on A.I.’s promise in medical research. The new technology is ...
Marketplace2d
“Superagency” explores how AI can enhance human potential to new heights
LinkedIn co-founder and AI investor Reid Hoffman argues we shouldn't be afraid of AI or its disruptive capabilities in his ...
Reid Hoffman-backed AI drug discovery startup Manas AI launches with $24.6M
Manas AI Inc., a startup using artificial intelligence to discover new medicines, launched today with $24.6 million in ...
The Daily Pennsylvanian1d
Wharton dean, LinkedIn founder discuss ‘Embracing AI with Purpose’ at Tarnopol lecture series
Dedicated to spotlighting global leaders, the Tarnopol series serves as a platform for addressing critical societal issues, ...
STAT6h
What models flourished in the first generation of health tech?
AI in drug development is a vague term that might mean many things, and today, Owkin is announcing it has enrolled the first patient in a phase 1 study of OKN4395, its “AI-optimized” candidate for ...